Cargando…
Pulmonary Tuberculosis in Children: A Forgotten Disease?
Even today, tuberculosis in childhood is a disease that is often undiagnosed and undertreated. In the absence of therapy with antituberculosis drugs, children in the first years of life have a high degree of severe forms and mortality. In these children, symptoms are often not very specific and can...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385511/ https://www.ncbi.nlm.nih.gov/pubmed/37512894 http://dx.doi.org/10.3390/microorganisms11071722 |
_version_ | 1785081425712644096 |
---|---|
author | Pelosi, Umberto Pintus, Roberta Savasta, Salvatore Fanos, Vassilios |
author_facet | Pelosi, Umberto Pintus, Roberta Savasta, Salvatore Fanos, Vassilios |
author_sort | Pelosi, Umberto |
collection | PubMed |
description | Even today, tuberculosis in childhood is a disease that is often undiagnosed and undertreated. In the absence of therapy with antituberculosis drugs, children in the first years of life have a high degree of severe forms and mortality. In these children, symptoms are often not very specific and can easily be confused with other diseases of bacterial, viral or fungal etiology, making diagnosis more difficult. Nevertheless, the introduction of new diagnostic techniques has allowed a more rapid identification of the infection. Indeed, Interferon gamma release assay (IGRA) is preferred to the Mantoux, albeit with obvious limitations in children aged <2 years. While the Xpert Mtb/RIF Ultra test is recommended as an initial diagnostic investigation of the gastric aspirate and/or stools in children with signs and symptoms of pulmonary tuberculosis. The drugs used in the treatment of susceptible and resistant TB are the same as those used in adults but doses and combinations are different in the pediatric age. In children, brief therapy is preferable in both the latent infection and the active disease, as a significant reduction in side effects is obtained. |
format | Online Article Text |
id | pubmed-10385511 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103855112023-07-30 Pulmonary Tuberculosis in Children: A Forgotten Disease? Pelosi, Umberto Pintus, Roberta Savasta, Salvatore Fanos, Vassilios Microorganisms Review Even today, tuberculosis in childhood is a disease that is often undiagnosed and undertreated. In the absence of therapy with antituberculosis drugs, children in the first years of life have a high degree of severe forms and mortality. In these children, symptoms are often not very specific and can easily be confused with other diseases of bacterial, viral or fungal etiology, making diagnosis more difficult. Nevertheless, the introduction of new diagnostic techniques has allowed a more rapid identification of the infection. Indeed, Interferon gamma release assay (IGRA) is preferred to the Mantoux, albeit with obvious limitations in children aged <2 years. While the Xpert Mtb/RIF Ultra test is recommended as an initial diagnostic investigation of the gastric aspirate and/or stools in children with signs and symptoms of pulmonary tuberculosis. The drugs used in the treatment of susceptible and resistant TB are the same as those used in adults but doses and combinations are different in the pediatric age. In children, brief therapy is preferable in both the latent infection and the active disease, as a significant reduction in side effects is obtained. MDPI 2023-06-30 /pmc/articles/PMC10385511/ /pubmed/37512894 http://dx.doi.org/10.3390/microorganisms11071722 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Pelosi, Umberto Pintus, Roberta Savasta, Salvatore Fanos, Vassilios Pulmonary Tuberculosis in Children: A Forgotten Disease? |
title | Pulmonary Tuberculosis in Children: A Forgotten Disease? |
title_full | Pulmonary Tuberculosis in Children: A Forgotten Disease? |
title_fullStr | Pulmonary Tuberculosis in Children: A Forgotten Disease? |
title_full_unstemmed | Pulmonary Tuberculosis in Children: A Forgotten Disease? |
title_short | Pulmonary Tuberculosis in Children: A Forgotten Disease? |
title_sort | pulmonary tuberculosis in children: a forgotten disease? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385511/ https://www.ncbi.nlm.nih.gov/pubmed/37512894 http://dx.doi.org/10.3390/microorganisms11071722 |
work_keys_str_mv | AT pelosiumberto pulmonarytuberculosisinchildrenaforgottendisease AT pintusroberta pulmonarytuberculosisinchildrenaforgottendisease AT savastasalvatore pulmonarytuberculosisinchildrenaforgottendisease AT fanosvassilios pulmonarytuberculosisinchildrenaforgottendisease |